Chapter 1389: Chapter 1050: High Fever Chapter 1389: Chapter 1050: High Fever At the Nandu Medical University Virus Laboratory, the K virus had been cultured, and subsequent work proceeded tensely but in an orderly fashion. For this experiment, researchers worked overtime to meet deadlines. They greatly valued the cooperation with Professor Yang Ping, as he had long been considered a godlike figure in everyone’s hearts.

At this moment, joy and excitement were written on the researchers’ faces, yet their actions were extremely careful and cautious. They knew that this time was different from the past; although the source virus was a harmless, safe virus, this time it would be used directly in human trials, and the slightest carelessness could endanger the safety of the experiment’s participants. Therefore, they maintained a high level of vigilance and focus at all times to ensure that each step was correct and to avoid any possible mistakes.

The K virus samples would undergo a series of tests, during which researchers needed to continuously observe and record data, analyze the results, with their gaze firm and focused, and every slight change in the data touched their hearts.

After standardized testing, the K virus met the laboratory conditions, and everyone breathed a sigh of relief. Everyone was aware of Professor Yang’s urgency for the experiment due to time constraints, so they all tried to cooperate in the hope of not delaying Professor Yang’s experiment.

The virus that passed inspection would enter the packaging process, which was extremely strict. They would seal a specific quantity of the virus in specially made biological reagent bottles in a sterile environment, make them bottle by bottle, then label and store them in the refrigerator, like vaccines. Their storage and transportation process was a traceable cold chain.

The moment those K virus biological reagents, ready for clinical trials at any time, were manufactured, the atmosphere in the laboratory reached a climax. Researchers cheered and celebrated with each other.

Regardless of whether this clinical trial would succeed or fail, they had taken a brand new step with Professor Yang Ping. They would be the first in the world to fuse a protein subunit that can initiate tumor cell apoptosis with a carrier virus, artificially creating a new type of virus, the first in the world capable of killing tumors; this virus would also create a new category in classification. Regardless of success or failure, their current work is to open a new field, and as participants, they were, of course, incredibly excited.

Through the protective goggles of his hazmat suit, Professor Zhang Zhiwei personally packed these preparations into the portable storage cooler. In recent days, Professor Zhang had been pondering Professor Yang Ping’s rushed, time-pressed laboratory method, which actually had certain advantages if other factors were disregarded.

According to the standard procedure, it begins with computer simulations, followed by animal experiments, then phase one, phase two, phase three clinical trials, and finally, clinical application. Now, by applying the virus directly to patients, Professor Yang Ping is not merely taking blind risks, but has conducted a very comprehensive assessment of this virus, making the probability of a risk incident extremely low. Meanwhile, the condition of the patients receiving treatment is very urgent, and there is no time to wait; this is also their only potentially effective method.

Considering both factors, comparing risk and benefit, Professor Yang Ping’s choice is undoubtedly brilliant. The immune systems of animals and humans are different, and so are the immune mechanisms, so there is still a very high risk when data from animal experiments are applied to humans. Even following the normal procedure, the phase one through three clinical trials still face risks, but they are compliant risks, whereas the risks Professor Yang Ping currently faces are non-compliant.

If one maintains absolute rationality, even if the patient doesn’t participate in the K virus experiment now, she doesn’t have much time left anyway. If the K virus experiment fails, it can still provide the most authentic and valuable data, which can be immediately revised, so the chances of success are still great.

After some thought over the past few days, Professor Zhang Zhiwei felt that cooperating with Professor Yang Ping in this experiment was like a pie falling from the sky. If Sanbo Hospital did not lack a P3 biosafety laboratory, such good fortune might not have been his. His team simply helped cultivate the virus and became a major participant in the experiment; such an experiment, regardless of success or failure, could occupy a top-tier position academically.

Thinking of this, Professor Zhang couldn’t help but feel a little shame for receiving undeserved rewards, as he shared Professor Yang Ping’s academic achievements by merely lending a hand; this reflects how Professor Yang is a scholar who cares little for such vanity, always considering experiments objectively without the slightest regard for such things. Professor Zhang held Professor Yang in the utmost respect.

Meanwhile, these young Doctors were very happy about this, as participating in this experiment meant they could potentially have a CNS paper upon graduation, implying that in just a few weeks, they might accomplish academic achievements that would take others decades to accumulate.

After the K virus reagent was boxed up, Professor Zhang Zhiwei led two Doctors to personally escort it to Sanbo Hospital.

—
Early in the morning, just after the shift handover, a car from Nandu Medical University had already arrived at Sanbo Hospital.

Professor Zhang Zhiwei carried the box containing the K virus biological agent himself, accompanied by two Doctors, to the independent ward of the Surgical Research Institute. This ward was specially set up for Sisi to facilitate her clinical trial. Professor Yang Ping spared no expense for this experiment.